SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SEOUL, South Korea , Sept. 15, 2025 /PRNewswire/ -- South Korean startup MAS9 has made a rapid entry into the U.S. Taekwondo market, onboarding more...
SAN BERNARDINO, Calif., Sept. 15, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it will significantly expand its exploration program at...
